162 related articles for article (PubMed ID: 32479245)
21. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
Bartuzi D; Kaczor AA; Matosiuk D
Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
[TBL] [Abstract][Full Text] [Related]
22. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
Burford NT; Watson J; Bertekap R; Alt A
Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
[TBL] [Abstract][Full Text] [Related]
23. Peripherally acting opioid analgesics and peripherally-induced analgesia.
Martínez V; Abalo R
Behav Pharmacol; 2020 Apr; 31(2&3):136-158. PubMed ID: 32168025
[TBL] [Abstract][Full Text] [Related]
24. Allosteric Modulators: A Side Door.
Abood ME
J Med Chem; 2016 Jan; 59(1):42-3. PubMed ID: 26645411
[TBL] [Abstract][Full Text] [Related]
25. Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.
Wootten D; Miller LJ
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():89-107. PubMed ID: 31454292
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of opioid-induced pain and antinociceptive tolerance: signal transduction.
Colpaert FC
Pain; 2002 Feb; 95(3):287-288. PubMed ID: 11839428
[No Abstract] [Full Text] [Related]
27. Emerging Insights into Mu Opioid Pharmacology.
Pasternak GW; Childers SR; Pan YX
Handb Exp Pharmacol; 2020; 258():89-125. PubMed ID: 31598835
[TBL] [Abstract][Full Text] [Related]
28. Allosteric Modulator Discovery: From Serendipity to Structure-Based Design.
Lu S; He X; Ni D; Zhang J
J Med Chem; 2019 Jul; 62(14):6405-6421. PubMed ID: 30817889
[TBL] [Abstract][Full Text] [Related]
29. Allosteric small molecule modulators of nuclear receptors.
Meijer FA; Leijten-van de Gevel IA; de Vries RMJM; Brunsveld L
Mol Cell Endocrinol; 2019 Apr; 485():20-34. PubMed ID: 30703487
[TBL] [Abstract][Full Text] [Related]
30. Biased Opioid Receptor Ligands: Gain without Pain.
Ranjan R; Pandey S; Shukla AK
Trends Endocrinol Metab; 2017 Apr; 28(4):247-249. PubMed ID: 28110810
[TBL] [Abstract][Full Text] [Related]
31. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.
Sengmany K; Singh J; Stewart GD; Conn PJ; Christopoulos A; Gregory KJ
Neuropharmacology; 2017 Mar; 115():60-72. PubMed ID: 27392634
[TBL] [Abstract][Full Text] [Related]
32. Opioids for chronic pain: molecular and genomic basis of actions and adverse effects.
Ahmedzai SH; Boland J
Curr Opin Support Palliat Care; 2007 Aug; 1(2):117-25. PubMed ID: 18685352
[TBL] [Abstract][Full Text] [Related]
33. Antinociceptive and nociceptive actions of opioids.
Ossipov MH; Lai J; King T; Vanderah TW; Malan TP; Hruby VJ; Porreca F
J Neurobiol; 2004 Oct; 61(1):126-48. PubMed ID: 15362157
[TBL] [Abstract][Full Text] [Related]
34. Cyclic endomorphin analogs in targeting opioid receptors to achieve pain relief.
Janecka A; Gentilucci L
Future Med Chem; 2014; 6(18):2093-101. PubMed ID: 25531970
[TBL] [Abstract][Full Text] [Related]
35. Current strategies toward safer mu opioid receptor drugs for pain management.
Ehrlich AT; Kieffer BL; Darcq E
Expert Opin Ther Targets; 2019 Apr; 23(4):315-326. PubMed ID: 30802415
[TBL] [Abstract][Full Text] [Related]
36. Physicochemical and Pharmacological Characterization of Permanently Charged Opioids.
Mazak K; Noszal B; Hosztafi S
Curr Med Chem; 2017; 24(33):3633-3648. PubMed ID: 28685673
[TBL] [Abstract][Full Text] [Related]
37. Multitarget opioid ligands in pain relief: New players in an old game.
Turnaturi R; Aricò G; Ronsisvalle G; Parenti C; Pasquinucci L
Eur J Med Chem; 2016 Jan; 108():211-228. PubMed ID: 26656913
[TBL] [Abstract][Full Text] [Related]
38. Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype.
Drakopoulos A; Moianos D; Prifti GM; Zoidis G; Decker M
ChemMedChem; 2022 Jul; 17(14):e202200169. PubMed ID: 35560796
[TBL] [Abstract][Full Text] [Related]
39. Human opiorphin: the lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory mice.
Popik P; Kamysz E; Kreczko J; Wróbel M
Behav Brain Res; 2010 Nov; 213(1):88-93. PubMed ID: 20438769
[TBL] [Abstract][Full Text] [Related]
40. Antinociceptive Effects of a Novel α2/α3-Subtype Selective GABA
Lewter LA; Fisher JL; Siemian JN; Methuku KR; Poe MM; Cook JM; Li JX
ACS Chem Neurosci; 2017 Jun; 8(6):1305-1312. PubMed ID: 28150939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]